Goserline Acetate VS Dienogest in Endometriosi

• Status: Recruiting
• Trial end date: 2021-12-25
• Target enrollment: 0
• Participant gender: Female

Summary

clinical trial aims to evaluate efficacy of dienogest (DNG) in comparison to goserline acetate in complete 12 week treatment of pain in women suffer from chronic pelvic pain diagnosed as endometriosis by laparoscopy and histopathology.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Mansoura University
• Treatments: Dienogest; Goserelin

Criteria

Inclusion Criteria:

• Non pregnant women confirmed to have endometriosis by histopathology and not received any hormonal treatment yet. Also, medical treatment was the proper choice for treatment of each case.

Exclusion Criteria:

• Women suspect pregnancy.

• Breast feeding women.

• Previous use of hormonal agents (progestin less than 6 months, danazol less than 3 month, oral contraceptive pills less than 1 month before screening).

• Women with other gynecological pathology interfere with treatment we will use.

• Using of corticosteroids.

• Family history of osteoporosis.